Entity Common Stock, Shares Outstanding of Cidara Therapeutics, Inc. from 10 Aug 2015 to 03 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cidara Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 10 Aug 2015 to 03 Nov 2025.
  • Cidara Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 03 Nov 2025 was 31,439,371, a 346% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Cidara Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 31,439,371 +24,392,738 +346% 03 Nov 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 25,358,051 +18,319,810 +260% 06 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 10,953,490 -80,281,530 -88% 27 Feb 2025 10-K 06 Mar 2025 2024 FY
Q3 2024 7,046,633 -83,387,144 -92% 04 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 7,038,241 -83,213,505 -92% 08 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 91,235,020 +2,226,608 +2.5% 12 Apr 2024 10-K 22 Apr 2024 2023 FY
Q3 2023 90,433,777 +18,815,686 +26% 31 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 90,251,746 +20,176,038 +29% 31 Jul 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 89,008,412 +19,958,915 +29% 16 Mar 2023 10-K 23 Mar 2023 2022 FY
Q3 2022 71,618,091 +4,932,037 +7.4% 31 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 70,075,708 +20,569,440 +42% 29 Jul 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 69,049,497 +20,759,702 +43% 29 Apr 2022 10-Q 11 May 2022 2022 Q1
Q3 2021 66,686,054 +22,748,176 +52% 29 Oct 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 49,506,268 +6,547,073 +15% 30 Jul 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 48,289,795 +7,543,265 +19% 30 Apr 2021 10-Q 13 May 2021 2021 Q1
Q3 2020 43,937,878 +10,897,583 +33% 31 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 42,959,195 +16,191,206 +60% 31 Jul 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 40,746,530 +14,104,679 +53% 30 Apr 2020 10-Q 13 May 2020 2020 Q1
Q3 2019 33,040,295 +5,288,864 +19% 31 Oct 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 26,767,989 -911,502 -3.3% 31 Jul 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 26,641,851 +5,250,794 +25% 30 Apr 2019 10-Q 09 May 2019 2019 Q1
Q3 2018 27,751,431 +7,513,288 +37% 31 Oct 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 27,679,491 +10,816,396 +64% 31 Jul 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 21,391,057 +4,585,015 +27% 30 Apr 2018 10-Q 10 May 2018 2018 Q1
Q3 2017 20,238,143 +3,564,857 +21% 31 Oct 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 16,863,095 +2,956,441 +21% 31 Jul 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 16,806,042 +2,951,250 +21% 30 Apr 2017 10-Q 10 May 2017 2017 Q1
Q3 2016 16,673,286 +2,953,621 +22% 31 Oct 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 13,906,654 +232,363 +1.7% 31 Jul 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 13,854,792 30 Apr 2016 10-Q 12 May 2016 2016 Q1
Q3 2015 13,719,665 10 Nov 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 13,674,291 10 Aug 2015 10-Q 11 Aug 2015 2015 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.